News
New Study Reveals Powerful New Method Can Distinguish Schizophrenia from Healthy Using Brain SPECT Imaging
4+ hour, 49+ min ago (344+ words) Morningstar The research represents an important step toward developing objective brain-based tools to support psychiatric diagnosis and treatment The study, led by researchers from the Tri-Institutional Center for Translational Research in Neuroimaging and Data Science (TRe NDS), Amen Clinics, and…...
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis
1+ mon, 2+ week ago (341+ words) Morningstar Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a "1. 17 million grant to support a randomized controlled trial at the…...
Most psychiatric practices lack a unified operational intelligence layer- often without realizing it
1+ mon, 3+ week ago (268+ words) WILMINGTON, Del. , May 12, 2026 Ahead of APA (American Psychiatric Conference) 2026 in San Francisco, the Saffron Solution, a healthcare technology and services company warns that disconnected systems, fractured workflows, and invisible operational leakage are quietly undermining psychiatric care delivery across the United…...
New Nature-Published Research Reviews How Metabolic Dysfunction May Be Core Driver in Psychiatric Diseases
3+ mon, 1+ week ago (561+ words) The Paper Emphasizes the Importance of Integrating Metabolic Approaches into Psychiatric Care and Explores the Relationship Between Systemic Metabolic Dysfunction and Mental Health The paper reviews 138 studies demonstrating the relationship between systemic and central metabolic dysfunction, such as abnormalities in…...
Core Spaces Offers Free Mental Health Services to 30, 000 Residents
10+ mon, 1+ week ago (286+ words) In Partnership with Talkspace, Student Housing Leader Brings Digital Therapy Directly to College Students Core Spaces, a vertically integrated real estate developer, operator and investment manager, announces an exclusive partnership with Talkspace, a leading online behavioral healthcare company, to offer…...
The Doctor's Office Offering Novel Technology Using Brain Stimulation to Treat Depression and Optimize Mental Health
9+ mon, 3+ week ago (215+ words) SALT LAKE CITY, Sept. 8, 2025 Launch Party on September 17 to Showcase New Treatment "Stress and depression can greatly interfere with our productivity and enjoyment of life," says Mark Cacciamani, M. D. , founder of The Doctor's Office, the in-office location of House Call Doctors....
PAX Health Acquires Neuropsychology and Counseling Associates, Expanding Comprehensive Mental Health Services Across New Jersey
9+ mon, 1+ week ago (374+ words) RED BANK, N. J. , Sept. 23, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (Nasdaq: HLNE), today announced its. .. PAX Health Acquires Neuropsychology and Counseling Associates, Expanding Comprehensive Mental Health Services Across New…...
Magellan Health White Paper Reveals Breakthrough in Pediatric Behavioral Health Outcomes through Collaborative Care
10+ mon, 3+ day ago (123+ words) FRISCO, Texas, Sept. 3, 2025 Team-based approach fosters clinical partnerships and provides tools to support physicians who treat children with mild to moderate behavioral health conditions FRISCO, Texas, Sept. 3, 2025 /PRNewswire/ -- Magellan Health, Inc. , a clinical-first leader in behavioral health and related services,…...
Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
10+ mon, 4+ week ago (269+ words) EMBRACE, the second study within the Phase 3 PARADIGM program, will enroll 330 participants at approximately 60 clinical sites across the United States, Europe, the United Kingdom, and Australia - - European CTA approval to initiate the EMBRACE study in Ireland, Poland, and Greece has…...
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
11+ mon, 1+ week ago (749+ words) Provided by Globe Newswire Jul 25, 2025, 8: 05: 00 PM. .....